
FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction
Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Share
Facebook
X
LinkedIn
Telegram
Tumblr
Whatsapp
VK
Mail